معرفی
Jonathan Livingstone-Banks is a Lecturer & Senior Researcher in Evidence-Based Healthcare at the University of Oxford, affiliated with the Centre for Evidence-Based Medicine and Oxford Tobacco Addiction Group. He holds a BA, MA, and PhD. His primary research focuses on tobacco control, particularly through evidence synthesis, and explores methodological advancements in this field. He is an Associate Editor for Nicotine & Tobacco Research, Cochrane Tobacco Addiction Group, and Cochrane Clinical Answers.
- Education: BA, MA, PhD
- Affiliations: Kellogg College, Cochrane Collaboration, Centre for Evidence-Based Medicine
His work addresses e-cigarette impact assessment, smoking cessation interventions, and the philosophy of evidence-based healthcare. He has published extensively on tobacco harm reduction, flavor effects, and policy implications of emerging nicotine products. Key funding sources include NIH, NIHR, and Cancer Research UK.
Recent research trends emphasize systematic reviews of behavioral interventions, pharmacological approaches, and public health policy analysis. Notably, he contributed to Cochrane reviews evaluating e-cigarette efficacy and incentive-based cessation programs.
- Grants: Over 15 funding bodies listed, including NIH, NIHR, and NICE
- Teams: Cochrane Tobacco Addiction Group, Oxford Tobacco Addiction Group
